These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 7674094)
1. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. Walker C; Dixon GR; Myskow M J Pathol; 1995 Jul; 176(3):319-20. PubMed ID: 7674094 [No Abstract] [Full Text] [Related]
2. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. Fontanini G; Vignati S; Bigini D; Merlo GR; Ribecchini A; Angeletti CA; Basolo F; Pingitore R; Bevilacqua G J Pathol; 1994 Sep; 174(1):23-31. PubMed ID: 7965400 [TBL] [Abstract][Full Text] [Related]
3. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304 [TBL] [Abstract][Full Text] [Related]
4. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer. Brambilla E; Gazzeri S; Lantuejoul S; Coll JL; Moro D; Negoescu A; Brambilla C Clin Cancer Res; 1998 Jul; 4(7):1609-18. PubMed ID: 9676834 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951 [TBL] [Abstract][Full Text] [Related]
6. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity. Kinoshita I; Dosaka-Akita H; Mishina T; Akie K; Nishi M; Hiroumi H; Hommura F; Kawakami Y Cancer Res; 1996 Dec; 56(24):5557-62. PubMed ID: 8971152 [TBL] [Abstract][Full Text] [Related]
7. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics. Kalomenidis I; Orphanidou D; Papamichalis G; Vassilakopoulos T; Scorilas A; Rasidakis A; Papastamatiou H; Jordanoglou J; Roussos C Lung; 2001; 179(5):265-78. PubMed ID: 11976895 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of p53 protein and prognosis of surgically resected non-small-cell lung cancer. Quantin X; Pujol JL; Lehmann M; Simony J; Serre I; Michel FB Cancer Detect Prev; 1997; 21(5):418-25. PubMed ID: 9307845 [TBL] [Abstract][Full Text] [Related]
9. p53 protein accumulates frequently in early bronchial neoplasia. Bennett WP; Colby TV; Travis WD; Borkowski A; Jones RT; Lane DP; Metcalf RA; Samet JM; Takeshima Y; Gu JR Cancer Res; 1993 Oct; 53(20):4817-22. PubMed ID: 8402667 [TBL] [Abstract][Full Text] [Related]
10. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069 [TBL] [Abstract][Full Text] [Related]
11. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
12. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. Dalquen P; Sauter G; Torhorst J; Schultheiss E; Jordan P; Lehmann S; Solèr M; Stulz P; Mihatsch MJ; Gudat F J Pathol; 1996 Jan; 178(1):53-8. PubMed ID: 8778317 [TBL] [Abstract][Full Text] [Related]
13. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth. Kushner J; Bradley G; Jordan RC J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258 [TBL] [Abstract][Full Text] [Related]
14. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766 [TBL] [Abstract][Full Text] [Related]
15. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism. Riva CM Anticancer Res; 2000; 20(6B):4463-71. PubMed ID: 11205289 [TBL] [Abstract][Full Text] [Related]
16. Field change, clonality, and early epithelial cancer: possible lessons from p53. Ogden GR; Hall PA J Pathol; 1997 Feb; 181(2):127-9. PubMed ID: 9120713 [No Abstract] [Full Text] [Related]
17. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis. Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526 [TBL] [Abstract][Full Text] [Related]
18. Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma. Hayashi H; Miyamoto H; Ito T; Kameda Y; Nakamura N; Kubota Y; Kitamura H Am J Pathol; 1997 Aug; 151(2):461-70. PubMed ID: 9250158 [TBL] [Abstract][Full Text] [Related]
19. Analysis of phosphorylated isoforms of the p53 tumor suppressor protein in human lung carcinoma cells undergoing apoptosis. Maxwell SA; Roth JA; Mukhopadhyay T Electrophoresis; 1996 Nov; 17(11):1772-5. PubMed ID: 8982610 [TBL] [Abstract][Full Text] [Related]
20. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis. Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]